Abstract
Cancer cells undergo metabolic changes that contribute to tumorigenesis, which can be determined using metabolomics data produced by techniques such as nuclear magnetic resonance and mass spectroscopy, and analyzed through statistical and machine learning methods. Since these data represent well the metabolic phenotype of these cells, they are very relevant in cancer research, to better understand tumour cells metabolism and help in efforts of biomarker and drug target discovery. This mini-review focuses on data analysis methods that are commonly used to extract knowledge from cancer metabolomics data, such as univariate analysis and supervised and unsupervised multivariate data analysis, including clustering and machine learning.
Keywords
- Cancer
- Metabolomics
- NMR
- Mass spectrometry
- Machine learning
- Chemometrics
This is a preview of subscription content, access via your institution.
Buying options
References
Warburg, O.: On the origin of cancer cells. Science 123(3191), 309–314 (1956)
Pavlova, N.N., Thompson, C.B.: The emerging hallmarks of cancer metabolism. Cell Metab. 23(1), 27–47 (2016)
Wang, H., et al.: Tissue metabolic profiling of human gastric cancer assessed by 1H NMR. BMC Cancer 16(1), 371 (2016)
Battini, S., et al.: Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. BMC Med. 15(1), 56 (2017)
Hart, C.D., et al.: Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicenter population. Clin. Cancer Res. 23(6), 1422–1431 (2017)
Belkaid, A., et al.: Metabolic effect of estrogen receptor agonists on breast cancer cells in the presence or absence of carbonic anhydrase inhibitors. Metabolites 6(2), 16 (2016)
Hao, D., et al.: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics 12(3), 58 (2016)
Fahrmann, J.F., et al.: Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer. Cancer Biomarkers 16(4), 609–617 (2016)
Mathé, E.A., et al.: Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res. 74(12), 3259–3270 (2014)
Zhu, J., et al.: Colorectal cancer detection using targeted serum metabolic profiling. J. Proteome Res. 13(9), 4120–4130 (2014)
Vermeersch, K., et al.: OVCAR-3 spheroid-derived cells display distinct metabolic profiles. PLoS One 10(2), e0118262 (2015)
Ranjbar, M., et al.: GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort. PLoS One 10(6), e0127299 (2015)
Amiot, A., et al.: 1 H NMR spectroscopy of fecal extracts enables detection of advanced Colorectal Neoplasia. J. Proteome Res. 14(9), 3871–3881 (2015)
Bertini, I., et al.: Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res. 72(1), 356–364 (2012)
Bhute, V.J., et al.: The poly (ADP-Ribose) polymerase inhibitor veliparib and radiation cause significant cell line dependent metabolic changes in breast cancer cells. Sci. Rep. 6(1), 36061 (2016)
Chan, A.W., et al.: 1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer. Br. J. Cancer 114(1), 59–62 (2016)
Fages, A., et al.: Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med. 13(1), 242 (2015)
Kim, H.S., et al.: Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy. PLoS One 12(6), e0179773 (2017)
Monteiro, M.S., et al.: Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci. Rep. 6(1), 37275 (2016)
Morin, P.J., et al.: NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas. J. Proteome Res. 12(5), 2165–2176 (2013)
Mun, J., et al.: Discrimination of basal cell carcinoma from normal skin tissue using high-resolution magic angle spinning 1H NMR spectroscopy. PLoS One 11(3), e0150328 (2016)
Roberts, M.J., et al.: Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: a preliminary investigation. Prostate Int. 5(4), 149–157 (2017)
Shao, W., et al.: Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy. Mol. Cancer 13(1), 197 (2014)
Tsai, I., et al.: Metabolomic dynamic analysis of hypoxia in MDA-MB-231 and the comparison with inferred metabolites from transcriptomics data. Cancers 5(2), 491–510 (2013)
Uifăalean, A., et al.: The impact of Soy Iso avones on MCF-7 and MDA-MB-231 breast cancer cells using a global metabolomic approach. Int. J. Mol. Sci. 17(9), 1443 (2016)
Yang, Q.J., et al.: Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J. Cachexia Sarcopenia Muscle 9(1), 1–15 (2017)
Miyamoto, S., et al.: Systemic metabolomic changes in blood samples of lung cancer patients identified by gas chromatography time-of-flight mass spectrometry. Metabolites 5(2), 192–210 (2015)
Batova, A., et al.: Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma. PLoS One 12(3), e0172632 (2017)
Xiao, J.F., et al.: LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort. J. Proteome Res. 11(12), 5914–5923 (2012)
Dhakshinamoorthy, S., et al.: Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia. Mol. BioSyst. 11(9), 2406–2416 (2015)
Mackay, E.: Fatty acid synthesis in colorectal cancer: characterization of lipid metabolism in serum, tumour, and normal host tissues. Ph.D. thesis, University of Calgary (2015)
Vermeersch, K.A., et al.: Distinct metabolic responses of an ovarian cancer stem cell line. BMC Syst. Biol. 8(1), 134 (2014)
Hilvo, M., et al.: Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients. Int. J. Cancer 134(7), 1725–1733 (2014)
Ressom, H.W., et al.: Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Analytica Chimica Acta 743, 90–100 (2012)
Abdi, H., Williams, L.J.: Principal component analysis. Wiley Interdisc. Rev. Comput. Stat. 2(4), 433–459 (2010)
Zhang, T., et al.: Application of holistic liquid chromatography-high resolution mass spectrometry based urinary metabolomics for prostate cancer detection and biomarker discovery. PLoS One 8(6), e65880 (2013)
Liu, R., et al.: Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Int. J. Mol. Sci. 14(5), 8899–8911 (2013)
Macqueen, J.: Some methods for classification and analysis of multivariate observations. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, vol. 1(233), pp. 281–297 (1967)
Locasale, J.W., et al.: Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol. Cellular Proteomics 11(6), M111.014688 (2012)
Wold, H.: Estimation of principal components and related models by iterative least squares. In: Multivariate Analysis, pp. 1391–1420 (1966)
Barker, M., Rayens, W.: Partial least squares for discrimination. J. Chemom. 17(3), 166–173 (2003)
Trygg, J., Wold, S.: Orthogonal projections to latent structures (OPLS). J. Chemom. 16(3), 119–128 (2002)
Breiman, L.: Random forests. Mach. Learn. 45(1), 5–32 (2001)
Liu, Y., et al.: NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis. Int. J. Cancer 135(3), 658–668 (2014)
Cortes, C., Vapnik, V.: Support-vector networks. Mach. Learn. 20(3), 273–297 (1995)
Chen, Y., et al.: Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via 1 H nuclear magnetic resonance spectroscopy. Cell Biol. Int. 9999, 1–10 (2017)
Gaul, D.A., et al.: Highly-accurate metabolomic detection of early-stage ovarian cancer. Sci. Rep. 5, 16351 (2015)
Costa, C., et al.: An R package for the integrated analysis of metabolomics and spectral data. Comput. Meth. Prog. Biomed. 129, 117–124 (2016)
Singh, A., et al.: 1H NMR metabolomics reveals association of high expression of inositol 1,4,5 trisphosphate receptor and metabolites in breast cancer patients. PLoS One 12(1), 1–20 (2017)
Haug, K., et al.: MetaboLights - an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res. 41(D1), D781–D786 (2013)
Acknowledgments
This work is co-funded by the North Portugal Regional Operational Programme, under the “Portugal 2020”, through the European Regional Development Fund (ERDF), within project SISBI- Ref\(^a\)NORTE-01-0247-FEDER-003381.
This study was also supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Cardoso, S., Baptista, D., Santos, R., Rocha, M. (2019). A Review on Metabolomics Data Analysis for Cancer Applications. In: Fdez-Riverola, F., Mohamad, M., Rocha, M., De Paz, J., González, P. (eds) Practical Applications of Computational Biology and Bioinformatics, 12th International Conference. PACBB2018 2018. Advances in Intelligent Systems and Computing, vol 803. Springer, Cham. https://doi.org/10.1007/978-3-319-98702-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-98702-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98701-9
Online ISBN: 978-3-319-98702-6
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)